معرفی
Dr. Naftali Kaminski is the Boehringer Ingelheim Endowed Professor of Internal Medicine and Chief of Pulmonary, Critical Care and Sleep Medicine at Yale School of Medicine. Previously, he held multiple tenured professorships at the University of Pittsburgh, including the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research and directorship of the Simmons Center for Interstitial Lung Disease. He received his medical degree from Hebrew University-Hadassah Medical School and completed clinical training at Hadassah Mount-Scopus University Hospital and Sheba Medical Center in Israel, followed by postdoctoral research at UCSF and Roche Bioscience.
- Research Focus: Genomics and systems biology of chronic lung diseases, particularly Idiopathic Pulmonary Fibrosis (IPF), COPD, and sarcoidosis
- Key Contributions: Discovery of microRNA roles in fibrosis, novel biomarkers for IPF outcomes, antifibrotic thyroid hormone signaling, and creation of the IPF Cell Atlas (www.IPFCellAtlas.com)
- Leadership: President of APCSD, Deputy Editor for Thorax, and Fellow of the European Respiratory Society and American Thoracic Society
Scientific Awards:
- Amberson Lecture Award (ATS, 2022)
- Andy Tager Excellence in Mentorship Award (ATS, 2018)
- Blavatnik Innovation Award (Yale, 2018)
- European Respiratory Society Gold Medal (2016)
- Helmholtz Institute International Fellow (2013)
Publications: Over 340 peer-reviewed articles in Nature Medicine, NEJM, Science Advances, and Lancet Respiratory Medicine, including recent single-cell RNAseq studies and computational models for fibrosis.